Literature DB >> 17608875

Effect of dementia and treatment of dementia on time to discharge from assisted living facilities: the Maryland assisted living study.

Constantine G Lyketsos1, Quincy M Samus, Alva Baker, Mathew McNabney, Chiadi U Onyike, Lawrence S Mayer, Jason Brandt, Peter Rabins, Adam Rosenblatt.   

Abstract

OBJECTIVES: To estimate the association between dementia and time to discharge from individual assisted living (AL) facilities and examine, in residents with dementia, factors associated with shorter duration of residence in individual AL facilities.
DESIGN: Prospective cohort study.
SETTING: Twenty-two AL facilities in central Maryland. PARTICIPANTS: Stratified random sample of 198 AL residents followed for a median of 18 months. MEASUREMENTS: Detailed assessments to diagnose dementia; assess treatment of dementia; and rate clinical; cognitive, functional, and quality-of-life measures.
RESULTS: Residents with dementia remained in a facility 209 fewer days at the median (P=.001) than residents without dementia. After adjustment for other variables, lack of treatment for dementia (P=.01) and more-serious medical comorbidity (P=.02) were associated with earlier discharge in participants with dementia. Impaired mobility and limited activity participation had weaker associations with earlier time to discharge.
CONCLUSION: Dementia may accelerate time to discharge, and its treatment may attenuate this effect. The hypothesis that the detection and treatment of dementia might delay discharge from AL should be tested in randomized trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17608875     DOI: 10.1111/j.1532-5415.2007.01225.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  6 in total

1.  Correlates of functional dependence among recently admitted assisted living residents with and without dementia.

Authors:  Quincy M Samus; Lawrence Mayer; Chiadi U Onyike; Jason Brandt; Alva Baker; Matthew McNabney; Peter V Rabins; Constantine G Lyketsos; Adam Rosenblatt
Journal:  J Am Med Dir Assoc       Date:  2009-06       Impact factor: 4.669

Review 2.  Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?

Authors:  Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-01       Impact factor: 3.485

3.  12-month incidence, prevalence, persistence, and treatment of mental disorders among individuals recently admitted to assisted living facilities in Maryland.

Authors:  Quincy M Samus; Chiadi U Onyike; Deirdre Johnston; Lawrence Mayer; Matthew McNabney; Alva S Baker; Jason Brandt; Peter V Rabins; Constantine G Lyketsos; Adam Rosenblatt
Journal:  Int Psychogeriatr       Date:  2013-01-07       Impact factor: 3.878

4.  The facade of stability in assisted living.

Authors:  Leslie A Morgan; Robert L Rubinstein; Ann Christine Frankowski; Rosa Perez; Erin G Roth; Amanda D Peeples; Mary Nemec; J Kevin Eckert; Susan Goldman
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-03-18       Impact factor: 4.077

5.  Cohort differences in dementia recognition and treatment indicators among assisted living residents in Maryland: did a change in the resident assessment tool make a difference?

Authors:  Quincy M Samus; Amrita Vavilikolanu; Lawrence Mayer; Matthew McNabney; Jason Brandt; Constantine G Lyketsos; Adam Rosenblatt
Journal:  Int Psychogeriatr       Date:  2013-09-23       Impact factor: 3.878

6.  The physical environment influences neuropsychiatric symptoms and other outcomes in assisted living residents.

Authors:  Mark C Bicket; Quincy M Samus; Mathew McNabney; Chiadi U Onyike; Lawrence S Mayer; Jason Brandt; Peter Rabins; Constantine Lyketsos; Adam Rosenblatt
Journal:  Int J Geriatr Psychiatry       Date:  2010-10       Impact factor: 3.485

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.